LAEKNA-B(02105)

13.220-1.160-8.07%

CommunityCommunity
NewsNews
ProfileProfile
AnnouncementsAnnouncements

Company Profile
Company Name
LAEKNA-B
Market
SEHK
Establishment Date
- -
Employees
- -
Office Location
- -
Website
http://www.laekna.com
Zip Code
- -
Phone
- -
Fax
- -
Introduction
Laekna Inc is an investment holding company mainly engaged in the discovery, development and commercialization of innovative therapies for cancer, liver diseases and obesity. The Company is still in the research and development stage. The Company's pipeline products include Afuresertib (LAE002), LAE001, LAE109, LAE111, LAE112, LAE113, LAE117, LAE118, LAE119, LAE102, LAE103, LAE104, LAE105, LAE106, LAE120, LAE123, and others. The Afuresertib is an adenosine triphosphate (ATP) competitive AKT inhibitor. The LAE001 is an androgen synthesis inhibitor that can inhibit CYP17A1 and CYP11B2 at the same time. The Company mainly conducts business in the Chinese, America, European, Korean, and other markets.

1D
5D
Day
Week
Month

Loading ...

High

14.960

Open

14.680

Volume%

2.12

Low

13.120

Close

14.380

T/O Rate

1.06%

抱歉，当前请求异常(-1)

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"pagemeta":{"title":"LAEKNA-B(02105),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest LAEKNA-B(02105) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"LAEKNA-B,02105,LAEKNA-B股票,LAEKNA-B股票老虎,LAEKNA-B股票老虎国际,LAEKNA-B行情,LAEKNA-B股票行情,LAEKNA-B股价,LAEKNA-B股市,LAEKNA-B股票价格,LAEKNA-B股票交易,LAEKNA-B股票购买,LAEKNA-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"LAEKNA-B(02105),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest LAEKNA-B(02105) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}},"tab":"summary","symbol":"02105","data":{"stockData":{"symbol":"02105","market":"HK","secType":"STK","nameCN":"LAEKNA-B","latestPrice":13.22,"timestamp":1742544503033,"preClose":14.38,"halted":0,"volume":4311648,"delay":0,"floatShares":408000000,"shares":408000000,"eps":-1.799291017525308,"marketStatus":"Market Closed","change":-1.16,"latestTime":"03-21 16:08:23","open":14.68,"high":14.96,"low":13.12,"amount":59485410,"amplitude":0.127955,"askPrice":13.26,"askSize":1500,"bidPrice":13.22,"bidSize":500,"shortable":0,"etf":0,"ttmEps":-0.888499717977825,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1742779800000},"marketStatusCode":7,"adr":0,"listingDate":1687968000000,"exchange":"SEHK","adjPreClose":14.38,"openAndCloseTimeList":[[1742520600000,1742529600000],[1742533200000,1742544000000]],"volumeRatio":2.120295063776725,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"tweetData":null,"newsData":null,"noticeData":{"listData":[],"currentPage":1,"bottom":true},"companyData":{"profile":{"websiteUrl":"http://www.laekna.com","stockEarnings":[{"period":"1week","weight":-0.0265},{"period":"1month","weight":0.1091},{"period":"3month","weight":0.4673},{"period":"6month","weight":1.8248},{"period":"1year","weight":1.0624},{"period":"ytd","weight":0.4109}],"compareEarnings":[{"period":"1week","weight":-0.0113},{"period":"1month","weight":0.0325},{"period":"3month","weight":0.2013},{"period":"6month","weight":0.2975},{"period":"1year","weight":0.4048},{"period":"ytd","weight":0.1809}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Laekna Inc is an investment holding company mainly engaged in the discovery, development and commercialization of innovative therapies for cancer, liver diseases and obesity. The Company is still in the research and development stage. The Company's pipeline products include Afuresertib (LAE002), LAE001, LAE109, LAE111, LAE112, LAE113, LAE117, LAE118, LAE119, LAE102, LAE103, LAE104, LAE105, LAE106, LAE120, LAE123, and others. The Afuresertib is an adenosine triphosphate (ATP) competitive AKT inhibitor. The LAE001 is an androgen synthesis inhibitor that can inhibit CYP17A1 and CYP11B2 at the same time. The Company mainly conducts business in the Chinese, America, European, Korean, and other markets.","exchange":"SEHK","name":"LAEKNA-B","nameEN":"LAEKNA-B"},"aProfile":null}}}